Compugen
CGEN
#8641
Rank
C$0.33 B
Marketcap
C$3.51
Share price
6.41%
Change (1 day)
70.93%
Change (1 year)

Earnings for Compugen (CGEN)

Earnings in 2026 (TTM): C$47.51 Million

According to Compugen's latest financial reports the company's current earnings are C$72.65 Million. In 2025 the company made an earning of C$49.91 Million, an increase over its 2024 earnings that were of -C$13.7 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Compugen from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$47.51 M-4.8%
2025 C$49.91 M-464.58%
2024 -C$13.7 Million-0.77%
2023 -C$13.8 Million-70.91%
2022 -C$47.44 Million-1.66%
2021 -C$48.24 Million15.17%
2020 -C$41.89 Million5.84%
2019 -C$39.57 Million24.16%
2018 -C$31.87 Million-39.03%
2017 -C$52.28 Million17.72%
2016 -C$44.41 Million59.22%
2015 -C$27.89 Million84.23%
2014 -C$15.14 Million-20.97%
2013 -C$19.16 Million-5.86%
2012 -C$20.35 Million20.44%
2011 -C$16.9 Million52.06%
2010 -C$11.11 Million3.26%
2009 -C$10.76 Million-37.67%
2008 -C$17.26 Million-3.37%
2007 -C$17.87 Million-8.64%
2006 -C$19.56 Million
2004 -C$21.97 Million9.57%
2003 -C$20.05 Million-5.5%
2002 -C$21.22 Million-20.9%
2001 -C$26.83 Million27.35%
2000 -C$21.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-C$1.12 Billion-2,366.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-C$5.46 Million-111.08%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
C$3.20 B 6,410.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Eterna Therapeutics
ERNA
-C$21.04 Million-142.76%๐Ÿ‡บ๐Ÿ‡ธ USA